This roadmap provides an in-depth analysis of Intel's current plans for its chip production capacity. In the space of 12 months, Intel has gone from canceling fabs to running short of them. In July last year, the company scrapped a planned €30 billion megafab in Magdeburg, Germany, and a $4.6 billion assembly and test plant near Wroclaw, Poland, citing a lack of committed demand. Then, in April this year, it paid Apollo $14.2 billion to repurchase the 49% stake in its Ireland fab that it had sold for $11.2 billion in 2024. Three weeks later, CFO David Zinsner described "unprecedented demand for silicon" alongside Q1 results that sent the stock up 24% in a single session, its best day since October 1987.

The next round of capacity development now hinges on two key deadlines: CEO Lip-Bu Tan told investors in January that prospective 14A customers will begin to make firm supplier decisions "starting in the second half of this year and extending into the first half of 2027." Separately, the enhanced 35% advanced manufacturing investment credit signed into law last July applies only to fab construction that begins before December 31st, 2026; projects that break ground in 2027 get nothing.

Luke James is a freelance writer and journalist.  Although his background is in legal, he has a personal interest in all things tech, especially hardware and microelectronics, and anything regulatory.